RUTI

BIOLOGICAL2 trials

Sponsors

Germans Trias i Pujol Hospital, Archivel Farma S.L.

Conditions

Latent Tuberculosis InfectionTuberculosis

Phase 1

Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers

CompletedNCT00546273

Germans Trias i Pujol HospitalLatent Tuberculosis Infection, Tuberculosis

Start: 2007-04-30End: 2008-06-30Updated: 2009-05-27

Phase 2

Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection

CompletedNCT01136161

Archivel Farma S.L.Latent Tuberculosis Infection, Tuberculosis

Start: 2010-06-30End: 2011-05-31Updated: 2013-01-24

Related Papers

Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infection

PLoS ONE2014-02-26136 citations